









Obagi CLENZIderm M.D.® Foaming Cleanser is a professional-strength, daily cleansing treatment formulated with 2% salicylic acid for oily, congested, blemish-prone and acne-prone skin. Its active foaming formula removes excess oil, impurities and pore-blocking dead skin while beginning the exfoliation process at the first stage of an Obagi skincare routine.
Unlike a conventional face wash that primarily removes surface debris, this lightweight cleanser uses an established concentration of oil-soluble beta hydroxy acid to penetrate oily build-up and help keep congested pores clear. Cooling menthol leaves the complexion feeling exceptionally clean and refreshed after rinsing.
Salicylic acid is an oil-soluble beta hydroxy acid, commonly abbreviated to BHA. This oil solubility allows it to work within the mixture of sebum and dead skin cells that can collect around the opening of a pore.
At a concentration of 2%, salicylic acid helps loosen and remove accumulated surface cells while supporting clearer-looking pores and a smoother skin texture. This makes CLENZIderm Foaming Cleanser particularly relevant when persistent oiliness, visible congestion, blackheads and recurring blemishes are central concerns.
Because the active ingredient is incorporated into the cleansing stage, the formula begins addressing pore congestion before leave-on products are applied. It is therefore more purposeful than using a basic cleanser alongside an otherwise active acne or blemish routine.
The CLENZIderm formula combines its 2% salicylic acid active with a high-foaming cleansing base that lifts away oil, cosmetic residue and impurities. Glycerin and chamomile flower extract are included within the supporting formulation, while menthol and menthyl lactate create its characteristic cooling finish.
The result is a decisive cleanse for skin that frequently feels oily, blocked or insufficiently refreshed by gentle cream cleansers. It leaves the skin prepared for a carefully selected leave-on exfoliant or treatment rather than leaving behind a heavy residue.
This cleanser may be suitable for adults concerned about:
Dry, highly sensitive or barrier-compromised skin may find frequent salicylic-acid cleansing too intensive. Introduce the product gradually and adjust its frequency according to how the skin responds.
Begin with once-daily use. If the skin tolerates the formula well and a skincare professional has recommended greater frequency, use may be increased gradually. If excessive dryness, peeling or discomfort develops, reduce application to once daily or every other day.
CLENZIderm Foaming Cleanser performs the first cleansing and exfoliating stage of the routine. It can be followed by Obagi CLENZIderm M.D.® Pore Therapy, a leave-on formulation that also contains 2% salicylic acid for more sustained contact with congested skin.
Because both products contain an active BHA concentration, they should be introduced thoughtfully rather than assuming that more frequent exfoliation will necessarily produce better results. A progressive routine helps maintain consistency while reducing avoidable dryness.
If benzoyl peroxide, prescription acne treatments, retinoids or other exfoliating acids are also being used, obtain individual guidance before combining them. The correct sequence and frequency will depend upon the complete routine and the skin’s tolerance.
The skin should feel thoroughly cleansed and refreshed immediately after use. Changes in visible congestion, texture and the frequency of blemishes require consistent use over time and depend on the remaining products in the routine.
Salicylic acid works by supporting the ongoing removal of pore-blocking build-up. For this reason, regular well-tolerated use is generally more valuable than occasional aggressive cleansing.
Yes. It contains 2% salicylic acid, an oil-soluble beta hydroxy acid used to exfoliate dead skin build-up and help keep congested pores clear.
Yes. The product is particularly suited to normal-to-oily and combination complexions affected by excess oil, congestion or recurring blemishes.
CLENZIderm Foaming Cleanser was developed for blemish-prone and acne-prone skin. Its 2% salicylic acid formula makes it a targeted cleansing option rather than a general-purpose face wash.
Some established users may tolerate twice-daily use, but it is sensible to begin once daily. Increase the frequency only if required and if the skin remains comfortable.
Yes, the products belong to the same CLENZIderm range. However, both contain 2% salicylic acid, so their combined frequency should be adjusted according to tolerance and professional guidance.
Active retinoids and salicylic acid can both increase dryness and visible peeling. Their use within the same routine should be introduced cautiously and personalised rather than automatically combined at maximum frequency.
Active ingredient: Salicylic Acid 2%.
Inactive ingredients: Butyl Avocadate, Cetyl Hydroxyethylcellulose, Chamomilla Recutita (Matricaria) Flower Extract, Cocamidopropyl Betaine, Disodium EDTA, Ethoxydiglycol, Ext. Violet 2, Fragrance, Glycerin, Menthol, Menthyl Lactate, Sodium Laureth Sulfate, Sodium Lauryl Sulfate, Water (Aqua).
Ingredient lists may be updated by the manufacturer. Refer to the product packaging for the current formulation if you have a known sensitivity or allergy.